Tharimmune Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Tharimmune, Inc. (THAR) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents3.5610.946.510.000.19
Cash & Short-Term Investments3.5610.946.510.000.19
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.050.010.180.070.10
Total Current Assets3.7210.956.690.620.29
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.000.000.000.000.00
Total Assets3.7210.956.690.620.29
Current Liabilities
Accounts Payable1.090.910.951.460.51
Short-Term Debt0.000.000.001.390.56
Current Portion of Long-Term Debt0.000.000.001.390.56
Accrued Liabilities1.320.910.190.500.32
Other Current Liabilities1.320.000.000.981.33
Total Current Liabilities2.411.821.144.532.73
Non-Current Liabilities
Long-Term Debt0.000.000.000.771.29
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.000.000.000.770.00
Total Liabilities2.411.821.145.314.01
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-36.90-24.70-15.38-6.91-4.70
Treasury Stock0.070.070.070.000.00
Additional Paid-in Capital38.2833.9021.002.230.00
Shares Outstanding1.970.780.030.030.00
Total Stockholders' Equity1.319.135.54-4.68-3.72
Total Liabilities & Equity3.7210.956.690.620.00